Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27339115

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Aug
First author
Dearnaley D

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Aug;17(8):1020-1022. doi: 10.1016/S1470-2045(16)30150-4.
    note
    Source null
    related pmid
    27339117
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2016 Aug;17(8):e321. doi: 10.1016/S1470-2045(16)30273-X.
    note
    Source null
    related pmid
    27350346
    relationship
    Erratum in
  3. citation
    Clin Oncol (R Coll Radiol). 2016 Dec;28(12):797. doi: 10.1016/j.clon.2016.08.008.
    note
    Source null
    related pmid
    27591001
    relationship
    Comment in
  4. citation
    Clin Oncol (R Coll Radiol). 2016 Dec;28(12):798-799. doi: 10.1016/j.clon.2016.09.002.
    note
    Source null
    related pmid
    27640308
    relationship
    Comment in
  5. citation
    Nat Rev Clin Oncol. 2016 Nov;13(11):655-656. doi: 10.1038/nrclinonc.2016.147.
    note
    Source null
    related pmid
    27644320
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2016 Dec;17(12):e517. doi: 10.1016/S1470-2045(16)30588-5.
    note
    Source null
    related pmid
    27924748
    relationship
    Comment in
  7. citation
    Lancet Oncol. 2016 Dec;17(12):e518. doi: 10.1016/S1470-2045(16)30592-7.
    note
    Source null
    related pmid
    27924749
    relationship
    Comment in
  8. citation
    Transl Androl Urol. 2016 Dec;5(6):966-967. doi: 10.21037/tau.2016.08.19.
    note
    Source null
    related pmid
    28078233
    relationship
    Comment in
  9. citation
    Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):718-721. doi: 10.1016/j.ijrobp.2016.11.038.
    note
    Source null
    related pmid
    28244406
    relationship
    Comment in

Authors and identifiers

  1. name
    Dearnaley D
    type
    Author
  2. name
    Syndikus I
    type
    Author
  3. name
    Mossop H
    type
    Author
  4. name
    Khoo V
    type
    Author
  5. name
    Birtle A
    type
    Author
  6. name
    Bloomfield D
    type
    Author
  7. name
    Graham J
    type
    Author
  8. name
    Kirkbride P
    type
    Author
  9. name
    Logue J
    type
    Author
  10. name
    Malik Z
    type
    Author
  11. name
    Money-Kyrle J
    type
    Author
  12. name
    O'Sullivan JM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dearnaley D
    type
    Author
  2. name
    Syndikus I
    type
    Author
  3. name
    Mossop H
    type
    Author
  4. name
    Khoo V
    type
    Author
  5. name
    Birtle A
    type
    Author
  6. name
    Bloomfield D
    type
    Author
  7. name
    Graham J
    type
    Author
  8. name
    Kirkbride P
    type
    Author
  9. name
    Logue J
    type
    Author
  10. name
    Malik Z
    type
    Author
  11. name
    Money-Kyrle J
    type
    Author
  12. name
    O'Sullivan JM
    type
    Author
bibliography ids
  1. nci-bib-6e2535b517017b94fa7f8767
book metadata
content sha256
7e4d696817ef73ba418bf4debfbe5779c8385fa6cbbc7a8f1cce7aad76c24141
document type
citation
dois
  1. 10.1016/S1470-2045(16)30102-4
electronic publication date
display
2016 Jun 20
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27339115
immutable id
pubmed:27339115@7e4d696817ef73ba418bf4debfbe5779c8385fa6cbbc7a8f1cce7aad76c24141
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
1047-1060
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Aug;17(8):1020-1022. doi: 10.1016/S1470-2045(16)30150-4.
    note
    Source null
    related pmid
    27339117
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2016 Aug;17(8):e321. doi: 10.1016/S1470-2045(16)30273-X.
    note
    Source null
    related pmid
    27350346
    relationship
    Erratum in
  3. citation
    Clin Oncol (R Coll Radiol). 2016 Dec;28(12):797. doi: 10.1016/j.clon.2016.08.008.
    note
    Source null
    related pmid
    27591001
    relationship
    Comment in
  4. citation
    Clin Oncol (R Coll Radiol). 2016 Dec;28(12):798-799. doi: 10.1016/j.clon.2016.09.002.
    note
    Source null
    related pmid
    27640308
    relationship
    Comment in
  5. citation
    Nat Rev Clin Oncol. 2016 Nov;13(11):655-656. doi: 10.1038/nrclinonc.2016.147.
    note
    Source null
    related pmid
    27644320
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2016 Dec;17(12):e517. doi: 10.1016/S1470-2045(16)30588-5.
    note
    Source null
    related pmid
    27924748
    relationship
    Comment in
  7. citation
    Lancet Oncol. 2016 Dec;17(12):e518. doi: 10.1016/S1470-2045(16)30592-7.
    note
    Source null
    related pmid
    27924749
    relationship
    Comment in
  8. citation
    Transl Androl Urol. 2016 Dec;5(6):966-967. doi: 10.21037/tau.2016.08.19.
    note
    Source null
    related pmid
    28078233
    relationship
    Comment in
  9. citation
    Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):718-721. doi: 10.1016/j.ijrobp.2016.11.038.
    note
    Source null
    related pmid
    28244406
    relationship
    Comment in
outcomes validated
false
pmid
27339115
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
c34dd1a149dd761dcece3b0f42f20515d86a1252801b57d466533f6b1620bbad
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Aug
precision
month
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27339115/
title
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Preserved source evidence · Not medical advice